A crosslinking strategy to make neutral polysaccharide nanofibers robust and biocompatible: With konjac glucomannan as an example. (1st July 2019)

• Record Type: Journal Article
• Authors: Zhang, Hui; Cui, Sisi; Lv, Huaxin; Pei, Xuejing; Gao, Meijiao; Chen, Sainan; Hu, Junli; Zhou, Yifa; Liu, Yichun
• Is Part Of: Carbohydrate polymers. Volume 215(2019)
• Page Start: 130
• Page End: 136
• Publication Date: 2019-07-01
• Subjects: Neutral polysaccharides -- Konjac glucomannan -- Nanofibers -- Crosslinking -- Water resistance -- Biocompatibility; Polysaccharides -- Periodicals; Polysaccharides -- Periodicals; Polysaccharides -- Périodiques; Electronic journals; 547.78
• DOI: 10.1016/j.carbpol.2019.03.075
• Languages: English
• ISSNs: 0144-8617

Abstract

Graphical abstract: Highlights: Crosslinked nanofibers of neutral polysaccharides were prepared. The nanofibers show excellent water resistance and biocompatibility. The nanofibers are expected to seek extensive biomedical applications. Abstract: Neutral polysaccharides such as konjac glucomannan, starch and pullulan are abundant in nature and have unique property. Their nanofibers hold great potential for biomedicine, which however, are seldom applied in the field due to the lack of crosslinking method. In this work, we report a periodate oxidation - adipic acid dihydrazide (ADH) crosslinking strategy to prepare robust and biocompatible neutral polysaccharide nanofibers. Neutral polysaccharides with adjacent dihydroxyl groups are firstly partially oxidized with periodate to give dialdehyde polysaccharides, and their electrospun nanofibers are then crosslinked with ADH to form dihydrazone crosslinkers. The resulting crosslinked neutral polysaccharide nanofibers exhibit high water resistance and excellent mechanical properties because of the high reactivity of Schiff base crosslinking reaction. Moreover, the crosslinked neutral polysaccharide nanofibers show good biocompatibility due to the low toxicity of ADH. These robust and biocompatible neutral polysaccharide nanofibers are expected to seek extensive applications in a variety of biomedical fields.